Page last updated: 2024-10-25

deferoxamine and Cancer of Mouth

deferoxamine has been researched along with Cancer of Mouth in 9 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research Excerpts

ExcerptRelevanceReference
"BQ chewing is the major risk factor of oral cancer in India, Taiwan, South Africa and numerous other countries."1.31Prevention of the areca nut extract-induced unscheduled DNA synthesis of gingival keratinocytes by vitamin C and thiol compounds. ( Chang, MC; Hahn, LJ; Ho, YS; Jeng, JH; Kok, SH; Lee, JJ, 2002)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (77.78)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, M1
Fujita, H1
Katase, N1
Inoue, K1
Nagatsuka, H1
Utsumi, K1
Sasaki, J1
Ohuchi, H1
Uekusa, M1
Omura, K1
Nakajima, Y1
Hasegawa, S1
Harada, H1
Morita, KI1
Tsuda, H1
Hershkovich, O1
Oliva, J1
Nagler, RM1
Lee, SK8
Lee, JJ2
Lee, HJ3
Lee, J4
Jeon, BH2
Jun, CD3
Kim, EC4
Jang, HJ1
Nakagawa, H1
Matsumiya, T1
Sakaki, H1
Imaizumi, T1
Kubota, K1
Kusumi, A1
Kobayashi, W1
Kimura, H1
Min, SK1
Won, DH1
Lee, YM1
Lim, HD1
Lee, W1
Pae, HO1
Chung, HT1
Chang, MC1
Ho, YS1
Kok, SH1
Hahn, LJ1
Jeng, JH1

Other Studies

9 other studies available for deferoxamine and Cancer of Mouth

ArticleYear
Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
    Acta medica Okayama, 2013, Volume: 67, Issue:3

    Topics: Amino Acid Chloromethyl Ketones; Aminolevulinic Acid; Apoptosis; ATP Binding Cassette Transporter, S

2013
Uptake and kinetics of 5-aminolevulinic acid in oral squamous cell carcinoma.
    International journal of oral and maxillofacial surgery, 2010, Volume: 39, Issue:8

    Topics: Amino Acids, Neutral; Animals; Carcinoma, Squamous Cell; Cell Differentiation; Deferoxamine; Drug Co

2010
Lethal synergistic effect of cigarette smoke and saliva in an in vitro model: does saliva have a role in the development of oral cancer?
    European journal of cancer (Oxford, England : 1990), 2004, Volume: 40, Issue:11

    Topics: Adult; Antioxidants; Cell Survival; Deferoxamine; Female; Free Radicals; Glutathione; Humans; In Vit

2004
Iron chelator-induced growth arrest and cytochrome c-dependent apoptosis in immortalized and malignant oral keratinocytes.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2006, Volume: 35, Issue:4

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Caspase 3; Caspase Inhibitors; Caspases

2006
p38 and ERK MAP kinase mediates iron chelator-induced apoptosis and -suppressed differentiation of immortalized and malignant human oral keratinocytes.
    Life sciences, 2006, Sep-05, Volume: 79, Issue:15

    Topics: Apoptosis; Caspase 3; Caspase 8; Caspases; Cell Differentiation; Cell Proliferation; Cytochromes c;

2006
Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma.
    Oral oncology, 2007, Volume: 43, Issue:6

    Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cycloheximide; Deferoxamine; Enzyme Inhibitors; Enzyme-L

2007
Differential regulation of iron chelator-induced IL-8 synthesis via MAP kinase and NF-kappaB in immortalized and malignant oral keratinocytes.
    BMC cancer, 2007, Sep-13, Volume: 7

    Topics: Cells, Cultured; Deferoxamine; Humans; Interleukin-8; Iron Chelating Agents; Keratinocytes; Mitogen-

2007
Iron chelator differentially activates macrophage inflammatory protein-3alpha/CCL20 in immortalized and malignant human oral keratinocytes.
    Archives of oral biology, 2008, Volume: 53, Issue:9

    Topics: Carcinoma, Squamous Cell; Chemokine CCL20; Deferoxamine; Enzyme-Linked Immunosorbent Assay; Female;

2008
Prevention of the areca nut extract-induced unscheduled DNA synthesis of gingival keratinocytes by vitamin C and thiol compounds.
    Oral oncology, 2002, Volume: 38, Issue:3

    Topics: Antioxidants; Areca; Ascorbic Acid; Cells, Cultured; Chelating Agents; Deferoxamine; DNA; Gingiva; H

2002